K130831 is an FDA 510(k) clearance for the MALDI BIOTYPER CA (MBT-CA) SYSTEM. Classified as System, Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates (product code PEX), Class II - Special Controls.
Submitted by Bruker Daltonics, Inc. (Beverly, US). The FDA issued a Cleared decision on November 21, 2013 after a review of 240 days - an extended review cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3361 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Bruker Daltonics, Inc. devices